Obesity and Multiple Sclerosis-A Multifaceted Association

被引:34
|
作者
Schreiner, Thomas-Gabriel [1 ,2 ,3 ]
Genes, Tudor-Marcel [1 ,2 ]
机构
[1] Clin Rehabil Hosp, Neurol Dept, Iasi 700661, Romania
[2] Univ Med & Pharm Gr T Popa, Fac Med, Iasi 700115, Romania
[3] Univ Med & Pharm Carol Davila, Fac Med, Bucharest 050474, Romania
关键词
multiple sclerosis; obesity; pathophysiology; chronic inflammation; adipokines; BODY-MASS INDEX; VITAMIN-D; METABOLIC SYNDROME; T-CELLS; TREATMENT RESPONSE; CHILDHOOD OBESITY; LEPTIN; DISEASE; ADIPONECTIN; RISK;
D O I
10.3390/jcm10122689
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Given the common elements in the pathophysiological theories that try to explain the appearance and evolution of obesity and multiple sclerosis, the association between the two pathologies has become an increasingly researched topic in recent years. On the one hand, there is the chronic demyelinating inflammation caused by the autoimmune cascade of multiple sclerosis, while on the other hand, according to the latest research, it has been shown that obesity shares an inflammatory component with most chronic diseases. Methods: The authors performed independent research of the available literature in the most important electronic databases (PubMed, Google Scholar, Embase, and Science Direct) in February 2021. After applying the exclusion criteria, the reviewers focused on the most relevant articles published during the last 10 years with respect to epidemiology and pathophysiology. Results: The data presented are a step forward in trying to elucidate the intricate relationship between obesity and MS, especially the causal relationship between childhood and adolescent obesity and MS, focusing on the epidemiological associations observed in the most relevant observational studies conducted in recent years. In the second part, the authors comment on the latest findings related to the pathophysiological mechanisms that may explain the correlations between obesity and multiple sclerosis, focusing also on the role of adipokines. Conclusions: Based on available epidemiological data, obesity in early life appears to be strongly associated with a higher risk of MS development, independent of other risk factors. Although much research has been done on the pathophysiology of obesity, MS, their possible common mechanism, and the role of adipokines, further studies are needed in order to explain what remains unknown. No relevant data were found regarding the association between obesity, disability (high EDSS score), and mortality risk in MS patients. Thus, we consider that this topic should be elucidated in future research.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] PYODERMA GANGRENOSUM IN A PATIENT WITH MULTIPLE SCLEROSIS-A RARE ASSOCIATION
    Phadke, P.
    Rodgers, S.
    Venkatesan, P.
    Selim, A.
    Puri, P.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (01) : 155 - 155
  • [2] Multiple sclerosis-a call for papers
    Brown, Heather
    [J]. LANCET NEUROLOGY, 2011, 10 (04): : 297 - 297
  • [3] Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis-a Prospective Study
    Drebinger, Daniel
    Rasche, Ludwig
    Kroneberg, Daniel
    Althoff, Patrik
    Bellmann-Strobl, Judith
    Weygandt, Martin
    Paul, Friedemann
    Brandt, Alexander U.
    Schmitz-Huebsch, Tanja
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [4] The utility of Magnetoencephalography in multiple sclerosis-A systematic review
    Khan, H.
    Sami, M. B.
    Litvak, V.
    [J]. NEUROIMAGE-CLINICAL, 2021, 32
  • [5] Association of obesity with disease outcome in multiple sclerosis
    Lutfullin, Isabel
    Eveslage, Maria
    Bittner, Stefan
    Antony, Gisela
    Flaskamp, Martina
    Luessi, Felix
    Salmen, Anke
    Gisevius, Barbara
    Klotz, Luisa
    Korsukewitz, Catharina
    Berthele, Achim
    Groppa, Sergiu
    Bergh, Florian Then
    Wildemann, Brigitte
    Bayas, Antonios
    Tumani, Hayrettin
    Meuth, Sven G.
    Trebst, Corinna
    Zettl, Uwe K.
    Paul, Friedemann
    Heesen, Christoph
    Kuempfel, Tania
    Gold, Ralf
    Hemmer, Bernhard
    Zipp, Frauke
    Wiendl, Heinz
    Luenemann, Jan D.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (01): : 57 - 61
  • [6] Multiple Sclerosis-A Tuning Fork Still Required
    Piehl, Fredrik
    [J]. JAMA NEUROLOGY, 2017, 74 (03) : 262 - 263
  • [7] Bariatric and metabolic surgery in patients with morbid obesity and multiple sclerosis-a nationwide, matched cohort study
    Stenberg, Erik
    Forsberg, Lars
    Hedstrom, Anna
    Hillert, Jan
    Naslund, Erik
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (06) : 1108 - 1114
  • [8] Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature
    Freiha, Joumana
    Riachi, Naji
    Chalah, Moussa A.
    Zoghaib, Romy
    Ayache, Samar S.
    Ahdab, Rechdi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 18
  • [9] Botulinum Toxin Treatment in Multiple Sclerosis-a Review
    Safarpour, Yasaman
    Mousavi, Tahereh
    Jabbari, Bahman
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (10)
  • [10] Tumefactive multiple sclerosis-a diagnostic and therapeutic challenge
    Galus, Weronika
    Zawislak-Fornagiel, Katarzyna
    Krzystanek, Ewa
    [J]. AKTUALNOSCI NEUROLOGICZNE, 2022, 22 (03): : 141 - 145